000 01256 a2200325 4500
005 20250510212356.0
264 0 _c19800712
008 198007s 0 0 eng d
022 _a0317-1671
024 7 _a10.1017/s031716710002388x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aNeophytides, A N
245 0 0 _aSodium valproate in the treatment of cerebellar disorders.
_h[electronic resource]
260 _bThe Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
_cNov 1979
300 _a455-7 p.
_bdigital
500 _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article
650 0 4 _aCerebellar Diseases
_xdrug therapy
650 0 4 _aClonazepam
_xtherapeutic use
650 0 4 _aDouble-Blind Method
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMuscimol
_xtherapeutic use
650 0 4 _aValproic Acid
_xadministration & dosage
700 1 _aTeychenne, P F
700 1 _aPfeiffer, R F
700 1 _aCalne, D B
773 0 _tThe Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
_gvol. 6
_gno. 4
_gp. 455-7
856 4 0 _uhttps://doi.org/10.1017/s031716710002388x
_zAvailable from publisher's website
999 _c118545
_d118545